Literature DB >> 813505

Anti-inflammatory drugs and renal papillary necrosis.

E H Wiseman, H Reinert.   

Abstract

The literature on renal papillary necrosis (RPN) associated with the administration of non-steroidal anti-inflammatory drugs (NSAID) to rats and man, is reviewed. RPN is almost universally reported after long term administration of NSAID to rats, reports being cited for an indomethacin analog, phenylbutazone, fenamic acids, fenoprofen and sudoxicam. Aspirin will also induce RPN in rats, and is probably the cause of the analgesic nephropathy' linked to abuse of aspirin/phenacetin combinations in man. RPN is reported at autopsy in human arthritics, but whether this is a facet of the disease, or of long term salicylate ingestion, is not clear. NSAID are rerely implicated in RPN in humans.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 813505     DOI: 10.1007/BF02205239

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  38 in total

1.  HISTOLOGICAL CHANGES IN RABBIT KIDNEYS INDUCED BY PHENACETIN AND ACETYLSALICYLIC ACID.

Authors:  E CLAUSEN
Journal:  Lancet       Date:  1964-07-18       Impact factor: 79.321

2.  PHENACETIN AND RENAL DAMAGE AT A SWEDISH FACTORY.

Authors:  K GRIMLUND
Journal:  Acta Med Scand       Date:  1963

3.  [Chronic interstitial nephritis].

Authors:  O SPUHLER; H U ZOLLINGER
Journal:  Z Klin Med       Date:  1953

4.  The origins of analgesic nephropathy.

Authors:  R M Murray
Journal:  Br J Psychiatry       Date:  1973-07       Impact factor: 9.319

5.  Renal abnormalities in rheumatoid arthritis.

Authors:  R J Bulger; L A Healey; P Polinsky
Journal:  Ann Rheum Dis       Date:  1968-07       Impact factor: 19.103

6.  Phenacetin nephropathy.

Authors:  L F Prescott
Journal:  Br Med J       Date:  1970-11-21

7.  Papillary necrosis following phenylbutazone ingestion.

Authors:  A Morales; J Steyn
Journal:  Arch Surg       Date:  1971-09

Review 8.  Aspirin and the kidney.

Authors:  R D Wigley
Journal:  N Z Med J       Date:  1971-11

9.  The association of peptic ulceration, chronic renal disease, and analgesic abuse.

Authors:  J K Dawborn; K F Fairley; P Kincaid-Smith; W E King
Journal:  Q J Med       Date:  1966-01

10.  Evidence for the nephrotoxicity of analgesics.

Authors:  M H Gault
Journal:  Can Med Assoc J       Date:  1972-10-21       Impact factor: 8.262

View more
  10 in total

1.  Life-threatening acute hyponatraemia induced by low dose cyclophosphamide and indomethacin.

Authors:  M J Webberley; J A Murray
Journal:  Postgrad Med J       Date:  1989-12       Impact factor: 2.401

Review 2.  The third Lilly Prize Lecture. University of London, January, 1979. The nephrotoxicity and hepatotoxicity of antipyretic analgesics.

Authors:  L F Prescott
Journal:  Br J Clin Pharmacol       Date:  1979-05       Impact factor: 4.335

3.  Naproxen and renal impairment.

Authors:  S J Ingram
Journal:  Br Med J       Date:  1979-05-05

4.  Benoxaprofen and papillary necrosis.

Authors:  L Erwin; J M Boulton Jones
Journal:  Br Med J (Clin Res Ed)       Date:  1982-09-11

5.  Reversible oliguric renal failure associated with ibuprofen treatment.

Authors:  R D Brandstetter; D D Mar
Journal:  Br Med J       Date:  1978-10-28

Review 6.  Analgesic nephropathy: a reassessment of the role of phenacetin and other analgesics.

Authors:  L F Prescott
Journal:  Drugs       Date:  1982 Jan-Feb       Impact factor: 9.546

Review 7.  Piroxicam. A reappraisal of its pharmacology and therapeutic efficacy.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-10       Impact factor: 9.546

Review 8.  Effects of non-narcotic analgesics on the kidney.

Authors:  P Kincaid-Smith
Journal:  Drugs       Date:  1986       Impact factor: 9.546

9.  Analgesic-associated nephropathy.

Authors:  A Schwarz
Journal:  Klin Wochenschr       Date:  1987-01-05

Review 10.  Piroxicam: a review of its pharmacological properties and therapeutic efficacy.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1981-09       Impact factor: 9.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.